The growing incidence of brain aneurysm and cerebral disorders is expected to drive the market growth. For instance, in 2014, approximately six million individuals were affected by an unruptured cerebral aneurysm in the US. Also, approximately 0.7 million strokes occur every year in the US.The rising demand for minimally invasive procedures is expected to fuel the adoption rates for neuroendovascular non-coils, owing to lesser complications.Therefore, neurosurgeons are shifting from their traditional approaches (surgical clipping) to advanced minimally invasive surgeries. Vendors are also focusing on developing minimally invasive devices. For instance, in February 2015, Medtronic received the US FDA approval for its flow diversion Pipeline Embolization Device,which is used for treating brain aneurysm. It is the first flow diversion device to receive approval from the US FDA.

PART 01: Executive summary 7

Highlights 7

PART 02: Scope of the report 9

Market overview 9

Top-vendor offerings 10

PART 03: Market research methodology 12

Research methodology 12

Economic indicators 12

PART 04: Introduction 13

Key market highlights 13

Neuroendovascular diseases: An overview 14

Brain aneurysm 17

Endovascular embolization 19

Regulatory environment 20

PART 05: Market landscape 23

Market overview 23

Five forces analysis 28

PART 06: Market segmentation by product type 29

Neuroendovascular stents 31

Access devices 34

Flow diversion devices 36

Other neuroendovascular non-coil devices 42

PART 07: Geographical segmentation 47

Neuroendovascular non-coils market in Americas 50

Neuroendovascular non-coils market in EMEA 52

Neuroendovascular non-coils market in APAC 53

PART 08: Market drivers 56

High incidence rates of brain aneurysm and cerebral

disorders 56

Growing demand for minimally invasive procedures with

improved medical imaging 56

Rise in demand for intracranial stenting procedures 57

Rise in recognition and awareness 58

PART 09: Impact of drivers 59

PART 10: Market challenges 60

Shortage of skilled surgeons and technicians 60

High cost of stenting procedures 60

Complications associated with neuroendovascular

procedures 61

Manufacturing hurdles and delay in product launch due

to stringent regulatory approvals 62

Lack of adequate clinical evidence 63

PART 11: Impact of drivers and challenges 65

PART 12: Market trends 66

Increase in market penetration of non-coil devices

through new technological advances 66

Growing surgeons' interests in adoption of flow diversion

devices and neurovascular stents 68

Growing number of ongoing clinical trials 69

Transforming marketing and sales strategies for

neuroendovascular non-coil devices 71

PART 13: Vendor landscape 75

Competitive scenario 75

Key news 78

PART 14: Key vendor analysis 80

DePuy Synthes 80

Medtronic 83

MicroVention 87

Stryker 91

Other prominent vendors 94

PART 15: Appendix 98

List of abbreviations 98

PART 16: Explore Technavio 99